NextServices

This week in the Scope Forward newsletter:   💡 GI Technology & Diagnostics - Colonoscopy still beats new blood tests at spotting colon cancer - Cook Medical launches PillSense, an ingestible capsule detecting GI bleeds with 93% sensitivity - A new study presented at the ACG 2024 meeting suggests that a wireless motility patch system could offer a more comprehensive, non-invasive way to monitor multiday GI activity 📈 Recognitions - Guardant Health named to TIME’s Best Inventions of 2024 for Shield™ - 2024 Healio Disruptive Innovators spotlight innovators in gastroenterology at ACG - Dr. Harish Gagneja named Master of the American College of Gastroenterology (MACG), placing him among 172 distinguished ACG members ⚖️ Legislation, Policy & Investment Impact - New legislation to block Medicare cuts and increase 2025 physician reimbursement gains momentum - AGA urges FDA to retain access to conventional FMT, following OpenBiome’s suspension of its FMT material distribution - Election implications for healthcare investing—Richard Close discusses how outcomes may shape healthcare equity and digital health investment 🤖 AI & Telehealth in GI Care - On-demand telehealth reduces GI-related ED visits and boosts patient satisfaction - AI tool helps detect pancreatic lesions with remarkable accuracy during endoscopic ultrasound 🏅 Clinical Updates - Lilly and J&J face off in Crohn’s disease at ACG 2024 with Phase III results #gastroenterology #innovation #AIinHealthcare #telehealth #healthpolicy #CRCscreening #disruptiveinnovators #ScopeForward

🚀 New on the Scope Forward Show! This interview is something truly unique. Maya, an AI avatar, takes the lead, asking thought-provoking questions about my new book, "The Shift". Together, we explore the future of gastroenterology and healthcare, discussing why this book matters and why now is the time for this conversation. The most intriguing part? By the end of the interview, what initially feels unconventional—an AI conducting an interview—will feel completely natural. And that’s how this shift is going to happen: so subtly that it'll seem like it's always been this way. I’m excited for you to experience this fun conversation—a glimpse into a future already unfolding before us. Let me know what you think. Here's where to get the book: https://lnkd.in/dcuw4_8P. #scopeforward #theshift #gimastermind Happy Deepavali to those celebrating! May your year be filled with light and inspiration.

Happy to share that my latest book The Shift hit #1 Amazon New Release lists in Gastroenterology, Scientific Education and Training and others. Buy the book on your local Amazon here: https://lnkd.in/dcuw4_8P. #theshift #gastroenterology #healthcare #future

See you at #ACG2024 Build your practice for the next decade: Automated Revenue Cycle: Transforming the way you manage revenue cycle with automation at its core. Cloud-based Endowriter & EHR: Refreshingly simple GI software -- without the bells and whistles. App & Health IT Development: Tailored tech solutions for your unique ideas. Data Analytics: Empowering decisions with actionable insights from data. #ACG2024 #gastroenterology #healthtech #healthcare

This week in the Scope Forward newsletter: 🚀 Investments & Expansions in GI Care - Oshi Health raises $60M Series C to strengthen its position as the category leader for virtual digestive care. - US Digestive Health welcomes seven new physicians to its practice. - Cylinder partners with Brown & Brown to expand access to digestive health solutions. ⚖️ Policy, Insurance & Legal Developments - Members of Congress introduce a bill to halt private equity ‘looting’ of healthcare entities - Gastroenterologists question the benefits and note potential harms of UHC's new program. - Gastroenterologist malpractice claims—what do doctors need to know to protect themselves? 🎯 Challenges & Opportunities in Practice Management - A wake-up call for physician-owned practices. - Physicians can help cut costs—they just need the right incentives. - How to create a 'symphony' in GI practice management. 📊 Clinical & Technological Updates - Microsoft launches new healthcare AI tools. - The true benefit of screening colonoscopy for CRC underestimated in the NordICC study. - Bowel prep quality and insurance barriers to care included in the October issue of AJG. 💡 Insights from Experts - Dr. Parikh sits down with Jeff Glueck, CEO and co-founder of Salvo Health, to discuss how their digital health platform is reshaping care for chronic GI diseases. - Beyond Ozempic: The future of obesity medicine with Dr. Mike Albert. #healthtech #gastroenterology #innovation #virtualcare #practicegrowth #healthpolicy #AIinHealthcare #ScopeForward

See you at #ACG2024 Build your practice for the next decade: Automated Revenue Cycle: Transforming the way you manage revenue cycle with automation at its core. Cloud-based Endowriter & EHR: Refreshingly simple GI software -- without the bells and whistles. App & Health IT Development: Tailored tech solutions for your unique ideas. Data Analytics: Empowering decisions with actionable insights from data. #ACG2024 #gastroenterology #healthtech #healthcare

This week in the Scope Forward newsletter: 🏆 Breakthroughs & Approvals in GI Care: - Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test - Zealand and Boehringer win FDA breakthrough status to treat fatty liver 📈 Gastroenterology: Industry Insights: - Gastroenterology is under pressure amid mounting challenges - 10 insights into GI compensation & workforce in 2024 - Top 20 hospitals by gastroenterology procedure volume 💼 Acquisitions & Partnerships - Pandora Health has announced its acquisition of OLVI Health 🧑⚕️ Physician Insights & Evolving Roles - GI Docs will need to forge a 'Human-Computer Cooperative’ - A recent survey highlights the growing need for gastroenterologists with expertise in cystic fibrosis - Dr. Doug Adler shares his experience transitioning from a 20-year academic career to a hybrid practice model - What physicians need to know about the medical malpractice landscape 🧠 Innovative Approaches to GI Care - Mindfulness and CBT combo improves quality of life in Crohn’s patients - Non-invasive, microbiome-based diagnosis of inflammatory bowel disease 🚀 AI & Tech Funding - Centaur Labs secures $16M in Series B funding to help health and scientific organizations accelerate AI development #gastroenterology #GIcare #innovation #healthtech #healthcare #CRCscreening #ScopeForward 

This week in the Scope Forward newsletter:   🏥 Practice Management - Navigating the pros and cons of selling your medical practice to private equity - 5 notes on the future of GI growth - Biosimilar costs escalate for GI practices 💼 Business - GI Alliance collaborates with Medtronic to introduce GI Genius™ AI technology for enhanced colon polyp detection - Geneoscopy receives a New York State Department of Health permit, expanding its ability to provide lab services nationwide 📱 Industry Disruptors & Innovations - Leveraging social media to enhance GI practice - Remote-controlled robot is changing the game for endoscopes - Robotic surgery for colorectal cancer reduces pain and speeds up recovery 🔬 Clinical Studies & Breakthroughs - The NordICC trial on colorectal cancer (CRC) screening might have underestimated 10-year risk reductions due to delays in cancer registration, affecting study outcomes - FDA grants breakthrough status to Sagimet's denifanstat to treat MASH with fibrosis - How 'obesity first' health care is transforming medicine 💼 Legal Matters - Bariatric surgeon to pay $45K to settle false claims allegations 🧠 GI Leadership - Dr. Laurie Keefer, co-founder of Trellus Health, discusses her innovative work in brain-gut behavior therapies for GI conditions like Crohn’s disease, ulcerative colitis, IBS, and GERD. - In a parallel universe, "I'd Be a Concert Pianist" says Tennessee GI   #ScopeForward #DigitalHealth #ArtificialIntelligence #Healthtech #Gastroenterology

💰 Competitive Landscape: - Guardant co-CEO offers $1 million bet that Exact Science's new screening test data won't hold up - The largest gastroenterology physician group practices are navigating an era of corporate consolidation. Is physician ownership of medical practices still a viable model?   🔬 Gut Health Innovation: - 24 top microbiome companies and startups are making waves in September 2024 - A digital digestive chronic care program is emerging as a promising tool to increase access for populations with chronic GI symptoms   🩸 Colorectal Cancer Screening: - Experts provide mixed opinions on the FDA's approval of a blood test for colorectal cancer (CRC) screening - Stool DNA testing kits like COLOTECT are emerging as viable, accessible alternatives to improve screening compliance - Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3   🍽️ Obesity Treatment Landscape: - Will new obesity drugs make bariatric surgery obsolete?   🤖 AI in Gastroenterology: - Positives, negatives and unknowns of AI-assisted colonoscopy   🧠 The Gut-Health Connection: - The future of medicine will revolve around our gut   🤝 Industry Partnerships: - Highmark and US Digestive Health have reached a new contract agreement   #GutHealth #ColorectalCancer #Microbiome #Obesity #HealthcareInnovation #Gastroenterology #ScopeForward

We often look for ideas outside of our surroundings. But what if an industry defining venture is staring at you right now, wherever you are? All it requires is for you to boldly take action. Just as Erica did. During her undergraduate research at Cornell University, Erica Barnell was involved in diagnosing environmental enteropathy in children in Africa—a silent gut inflammation that leads to growth faltering. Traditional diagnostic methods weren't feasible due to limited resources, so mothers sent their children's diapers for analysis. Erica and her team developed a groundbreaking technique to isolate human cells from the diapers, analyze the transcriptome, and identify affected children for timely intervention. This innovative approach sparked a pivotal question for Erica: Why not apply this non-invasive technology in the U.S. for conditions like colon cancer, IBD, IBS, and celiac disease? Encouraged by her principal investigator but realizing he wouldn't pursue it himself, she decided to take the initiative. Upon entering an MD-PhD program, Erica Barnell pulled the technology out of the university and founded Geneoscopy. Starting with $6.9 million before the pandemic, the company went on to raise $105 million in 2021 to develop and enhance its non-invasive RNA screening test. As of my interview, the company was raising another $100 million. That's how it happens. Stop stopping yourself and take action. ** Thank you Erica Barnell for these words below and the work you do. Be the first to know: https://lnkd.in/duBvpfTA.